If you have trouble remembering whether you took medication on time, the medication might have the answer soon, can be transplanted small chips in drugs dealing everything from the common cold to diabetes or cancer, and can show whether a patient may take medication on schedule or not, and these chips can drive patients to take the medicine and even ask them to taking a walk if they remain inactive for a very long time.
Said Eric Topol, chief academic officer at Scripps Health Health Services Foundation, a non-profit "People generally do not take their medication only for half the time .. commitment really a big issue in all forms of treatment."
May not like some of the follow-up of patients consuming the drug, but the system can also help to Compliance pharmaceutical vehicle in situations such as diabetes or heart.
Kelly said Claus is sick Diabetes Foundation (dia-tribe), which issued bulletins for people with diabetes, "this way in order to be a friend take care of me as my doctor can not be present all the time." They have not yet experienced this technology.
And approved the Food and Drug Administration on the sensor chip in the past month and attracted Company (Proteus Digital Health), which invented the chip investments from Novartis Swiss giant pharmaceutical company Japanese Otsuka Holdings. And other investors medical device companies (Medtronic) and Foundation (St. Jude Medical) and manufacturer of chips (Enter Simi Koncanuto).
Said George Savage co-founder of Proteus and chief Tabeyen "is not the purpose of this technology is to tell the patient that he was sick bad but that there be accurate data." And sensor chip that are being ingested connected Blasqh plastered on the trunk of the patient and pick up the report, which sends the chip.
And no sensor chip - and its size is almost identical size of a grain salt - battery or antenna works when it reaches the stomach acid. This represents complement the circle between the outer envelope composed of copper and magnesium on either side of what is happening electric current is limited to a few minutes.
Recorded lenses placed on the body message digital along with pulse patient and the angle of the body and its activity and send data to a device with Bluetooth feature such as phone or computer. Said Savage "Think about it like an advanced version of the technology Morse code telegraph." Then being load data to network computer, both for patients and medical service providers and physicians.
The system allows users to set an alarm to remind them to take medicine or alert if the patient remains idle for a specified period. Novartis tested sensor chip devised by Proteus in kidney transplant patients who are class are required to regularly take severe anti-rejection drugs transplanted organ.
Jolie said Massu Novartis spokeswoman, "the results of the study show that when using the Proteus system properly it follows the behavior of the patient in taking the drug with a very high degree of accuracy."
Savage said Proteus company working on the production of copies of expired drugs own intellectual property rights and received selling like hot cakes for the treatment of Type II diabetes and congestive heart failure and mental health disorders, a chip planted drugs. He did not say these drugs by name.
The company said that the tests included Proteus 254 people used the system for a period of 3828 days of them patients infected with tuberculosis, heart failure and high blood pressure.
Proteus partnership with the Bill and Melinda Gates Foundation and the Center for Disease Control and Prevention (CDC) in China to experience the new technology for the treatment of pulmonary tuberculosis. Gates Foundation awarded $ 560 thousand for the Proteus to support the pilot study of the technology on the TB patients in China.
And handles highly contagious TB is usually treated with strong antibiotics have unfavorable side effects making patients abandon taking the drug and putting others at risk.
Experts say in the health field that this raises the question of how to accept the system in some patients who may be one of the largest beneficiaries.
Topol said the Scripps Health Organization "Some may not want in a sticky situation and taking the drug because they may feel that they are subject to severe control.".
